{
  "id": 18317429,
  "title": "T-Therapeutics reloads with a $133M megaround for bispecifics",
  "url": "https://urgent.news/2026/11/05/t-therapeutics-reloads-with-a-133m-megaround-for-bispecifics",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T12:52:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/t-therapeutics-series-b-tces-bispecifics-cancer-autoimmune/873786/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The startup is built around technology it claims can help get after known, but undruggable cancer targets and design particularly selective autoimmune disease treatments.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}